Skip to main content
SpringerLink
Log in

Psychoactive Effects of Medical Drugs

  • Chapter
Practitioner’s Guide to Psychoactive Drugs for Children and Adolescents

  • 134 Accesses

Abstract

This chapter addresses the psychoactive effects of general medical drugs used in the treatment of children and adolescents with physical illnesses rather than psychotropic drugs prescribed for psychiatric or behavioral indications. “Psychoactive effects” will refer to acute or subacute effects in the behavioral, emotional, or cognitive domain. Anticonvulsant (antiepileptic) drugs are covered in Chapter 12. To avoid wordy repetition, the term “children” will mean “children and adolescents” unless otherwise indicated.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Elliger TJ, Trott GE, Nissen G: Prevalence of psychotropic medication in childhood and adolescence in the Federal Republic of Germany. Pharmacopsychiatry 232:38–44, 1990.

    Article  Google Scholar 

  2. Australian Bureau of Statistics: Australian Health Survey Catalogue No. 4311.0, 1983.

    Google Scholar 

  3. Rylance GW, Woods CG, Cullen RE, et al: Use of drugs by children. Br Med J 297:445–448, 1988.

    Article  Google Scholar 

  4. Csik V, Molnar J: Possible adverse interaction between clozapine and ampicillin in an adolescent with schizophrenia. J Child Adolesc Psychopharmacol 4:123–128, 1994.

    Article  Google Scholar 

  5. Popper C: Developmental neurotoxicity, in Popper C (ed): Psychiatric Pharmacosciences of Children and Adolescents. Washington DC, American Psychiatric Press, 1989.

    Google Scholar 

  6. Rosenberg DA: Web of deceit: A literature review of Munchausen syndrome by proxy. Child Abuse Neglect 11:547–563, 1987.

    Article  PubMed  Google Scholar 

  7. Whitlock FA: Adverse psychiatric reactions to modern medication. Aust N Z J Psychiatry 15:87–103, 1981.

    Article  PubMed  Google Scholar 

  8. Harper CM, Newton PA, Walsh JR: Drug induced illness in the elderly. Postgrad Med 86:245–256, 1989.

    PubMed  Google Scholar 

  9. Hollister LE: Drug-induced psychiatric disorders and their management. Med Toxicol 1:428–448, 1986.

    PubMed  Google Scholar 

  10. Stoudemire A, Fogel BS: Principles of Medical Psychiatry. New York: Harcourt Brace & Jovanovich Publishers, 1989.

    Google Scholar 

  11. Dukes MNG: Meyler’s Side Effects of Drugs: An Encyclopaedia of Adverse Reactions and Interactions, ed 11. Amsterdam, Elsevier, 1988.

    Google Scholar 

  12. Dukes MNG, Beeley L: Side Effects of Drugs Annual 13: A Worldwide Yearly Survey of New Data and Trends. Amsterdam, Elsevier, 1989.

    Google Scholar 

  13. Boston Collaborative Drug Surveillance Program: Side effects of non-psychiatric drugs. Semin Psychiatry 3:406–420, 1971.

    Google Scholar 

  14. Evans LES: Psychological effects caused by drugs in overdose. Drugs 19:220–242, 1980.

    Article  PubMed  Google Scholar 

  15. McClelland HA: Psychiatric disorders, in Davis DM (ed). Textbook of Adverse Drug Reactions. London: Oxford University Press, 1977, pp. 335–353.

    Google Scholar 

  16. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, DC, American Psychiatric Association Press, 1994.

    Google Scholar 

  17. Rachelefsky GS, Wo J, Adelson J, et al: Behavior abnormalities and poor school performance due to oral theophylline use. Pediatrics 78:1133–1138, 1986.

    PubMed  Google Scholar 

  18. Weinberger M, Lindgren S, Linder B, et al: Effects of theophylline on learning and behavior: Reason for concern or concern without reason? J Pediatr 111:471–474, 1987.

    Article  PubMed  Google Scholar 

  19. Lindgren S, Lokshin B, Stromquist A, Weinberger M, et al: Does asthma or treatment with theophylline limit children’s academic performance? N Engl J Med 327:926–930, 1992.

    Article  PubMed  Google Scholar 

  20. Tiplady B, Fagan D, Lamont M, Brockway M, Scott DB: A comparison of the CNS effects of enprofylline and theophylline in healthy subjects assessed by performance testing and subjective measures. Br J Clin Pharmacol 30:55–61, 1990.

    Article  PubMed  Google Scholar 

  21. Suess WM, Chai H: Neuropsychological correlates of asthma: Brain damage or drug effects? J Consult Clin Psychol 49:135–136, 1981.

    Article  PubMed  Google Scholar 

  22. Butz AM, Malveaux FJ, Eggleston P, Thompson L, et al: Social factors associated with behavioral problems in children with asthma. Clin Pediatr 34:581–590, 1995.

    Article  Google Scholar 

  23. Creer TL, Gustafson KE: Psychological problems associated with drug therapy in childhood asthma. J Pediatr 115:850–855, 1989.

    Article  PubMed  Google Scholar 

  24. Furukawa CT, DuHamel TR, Weimer L, et al: Cognitive and behavioral findings in children taking theophylline. J Allergy Clin Immunol. 81:83–88, 1988.

    Article  PubMed  Google Scholar 

  25. Schlieper A, Alcock D, Beaudry P, et al: Effect of therapeutic plasma concentrations of theophylline on behavior, cognitive processing and affect in children with asthma. J Pediatr 118:449–455, 1991.

    Article  PubMed  Google Scholar 

  26. Creer TL, McLoughlin JA: The effects of theophylline on cognitive and behavioral performance. J Allergy Clin Immunol 83:1027–1029, 1989.

    Article  PubMed  Google Scholar 

  27. Bartel P, Delport R, Lotz B, Ubbink J, et al: Effects of single and repeated doses of theophylline on aspects of performance, electrophysiology, and subjective assessments in healthy human subjects. Psychopharmacol-ogy 106:90–96, 1992.

    Article  Google Scholar 

  28. Schraa JC, Dirks JF: The influence of corticosteroids and theophylline on cerebral function. Chest 82:181 – 185, 1982.

    Article  PubMed  Google Scholar 

  29. Bender BG, Lerner JA, Kollasch E: Mood and memory changes in asthmatic children receiving corticosteroids. J Am Acad Child Adolesc Psychiatry 27:720–725, 1988.

    Article  PubMed  Google Scholar 

  30. Suess W, Stump N, Chi H, et al: Mnemonic effects of asthma medication in children. J Asthma 23:291–296, 1986.

    Article  PubMed  Google Scholar 

  31. Lewis LD, Cochrane GM: Psychosis in a child inhaling budesonide. Lancet 2:634, 1983.

    Article  PubMed  Google Scholar 

  32. Meyboom RHB, DeGraaf-Breederveld N: Budesonide and psychic side effects. Ann Intern Med 109:683, 1988.

    Article  PubMed  Google Scholar 

  33. Hollman GA, Allen DB: Overt glucocorticoid excess due to inhaled corticosteroid therapy. Pediatrics 81: 452–455, 1988.

    PubMed  Google Scholar 

  34. Rohatiner AZS, Proir PF, Burton AC, et al: Central nervous system toxicity of interferon. Br J Cancer 47:419–442, 1983.

    Article  PubMed  Google Scholar 

  35. Spiegel RF: The alpha-interferons: Clinical overview. Semin Oncol 14(suppl 2):1–12, 1987.

    PubMed  Google Scholar 

  36. Cousens P, Waters BGH, Said J, et al: Cognitive effects of cranial-irradiation in leukemia: A survey and metaanalysis. Child Psychol Psychiatry 29:839–852, 1988.

    Article  Google Scholar 

  37. Waters BGH, Said J, Cousens P, et al: Behavioral side effects of CNS prophylaxis. J Am Acad Child Adolesc Psychiatry 28:299–300, 1989.

    Article  PubMed  Google Scholar 

  38. Prugh DG, Wagonfeld S, Metcalf D, et al: A clinical study of delirium in children and adolescents. Psychosom Med 42(suppl):177–195, 1980.

    PubMed  Google Scholar 

  39. Lipowski ZJ: Delirium (acute confusional states). JAMA 258:1789–1792, 1987.

    Article  PubMed  Google Scholar 

  40. Trzepacz PT, Teague GB, Lipowski ZJ: Delirium and other organic mental disorders in a general hospital. Gen Hosp Psychiatry 7:101–106, 1985.

    Article  PubMed  Google Scholar 

  41. Goodman JD, Sours JA: The Child Mental Status Examination. New York: Basic Books, 1967.

    Google Scholar 

  42. McEwen J, Meyboom RH, Thijs I: Hallucinations in children caused by oxolamine citrate. Med J Aust 150:449–450,452, 1989.

    PubMed  Google Scholar 

  43. Kortabarria RP, Duran JA, Chacon JR, et al: Toxic psychosis following cycloplegic eyedrops. Drug Intell Clin Pharm 24:708–709, 1990.

    Google Scholar 

  44. Eisendrath S J, Ostroff JW: Ranitidine-associated delirium. Psychosomatik 31:98–100, 1990.

    Article  Google Scholar 

  45. Sax MJ: Clinically important adverse effects and drug interactions with H2-receptor antagonists: An update. Pharmacotherapy 7:110S-115S, 1987.

    Google Scholar 

  46. Ahamad S, Sheikh AI, Meerian MK: Disopyramide-induced acute psychosis. Chest 16:712–714, 1979.

    Article  Google Scholar 

  47. Bushe VJ: Organic psychosis caused by diltiazem. J R Soc Med 81:296, 1988.

    Google Scholar 

  48. Johnson AJ, Day RO, Shaldon WA: A functional psychosis precipitated by quinidine. Med J Aust 153:47–49, 1990.

    PubMed  Google Scholar 

  49. Arbor N: Delirium induced by atenolol. Br Med J 297:1048, 1988.

    Article  Google Scholar 

  50. Banergee AK, Falkai PG, Savidge M: Visual hallucinations in the elderly associated with the use of levodopa. Postgrad Med J 65:358–361, 1989.

    Article  Google Scholar 

  51. Snoey ER, Bessen HA: Acute psychosis after amantadine overdose. Ann Emerg Med 19:668–670, 1990.

    Article  PubMed  Google Scholar 

  52. Silber TJ, D’Angelo L: Psychosis and seizures following the injection of penicillin G procaine: Hoigne’s syndrome. Am J Dis Child 139:335–337, 1985.

    PubMed  Google Scholar 

  53. Ilechukwu STC: Acute psychotic reactions and stress response syndromes following intramuscular aqueous procaine penicillin. Br J Psychiatry 156:554–559, 1990.

    Article  PubMed  Google Scholar 

  54. Arndt KA: Adverse reactions to acyclovir: Topical, oral, and intravenous. J Am Acad Dermatol 18:188–190, 1988.

    Article  PubMed  Google Scholar 

  55. Meyers EF, Charles P: Prolonged adverse reactions to ketamine in children. Anesthesiology 49:39–40, 1978.

    Article  PubMed  Google Scholar 

  56. Holm-Knudsen R, Nygard E, Laub M: Rectal induction of anesthesia in children: A comparison between ketamine-midazolam and halothane for induction and maintenance of anesthesia. Acta Anaesthesiol Scand 33:518–521, 1989.

    Article  PubMed  Google Scholar 

  57. Hurwitz RL, Mahoney DH Jr, Armstrong DL, et al: Reversible encephalopathy and seizures as a result of conventional vincristine administration. Med Pediatr Oncol 16:216–219, 1988.

    Article  PubMed  Google Scholar 

  58. Young D, Posner J: Nervous system toxicity of the chemotherapeutic agents, in Viken PJ, Bruyn GW (eds). Handbook of Clinical Neurology, vol 39, pt II. Amsterdam, Elsevier Biomedical Press, 1980.

    Google Scholar 

  59. Cuthbert MF: Adverse reactions to nonsteroidal antirheumatic drugs. Curr Med Res Opin 2:600–610, 1974.

    Article  PubMed  Google Scholar 

  60. Greer HD, Ward HP, Corbin KB: Chronic salicylate intoxication in adults. JAMA 193:555–558, 1965.

    Article  PubMed  Google Scholar 

  61. Elliott RL, Wilde JH, Snow WT: Prolonged delirium after metrizamide myelography. JAMA 252:2057–2058, 1984.

    Article  PubMed  Google Scholar 

  62. Haslam RHA, Cochrane DD, Amundson GM, et al: Neurotoxic complications of contrast computed tomography in children. J Pediatr III 6:837–840, 1987.

    Article  Google Scholar 

  63. Montastruc JL, Rascol D, Rascol A: Comparison of bromocriptine and levodopa as first line treatment for Parkinson’s disease: Results of a 3 year prospective randomized study. Rev Neurol 146:144–147, 1990.

    PubMed  Google Scholar 

  64. Havener WH: Ocular Pharmacology, ed 4. St. Louis, CV Mosby Co, 1978.

    Google Scholar 

  65. Khanna PB, Davies R: Hallucinations associated with administration of salbutamol via a nebulizer. Br Med J 292:1430, 1986.

    Article  Google Scholar 

  66. Krauthammer C, Klerman GL: Secondary mania: Manic syndromes associated with antecedent physical illness or drugs. Arch Gen Psychiatry 35:1333–1339, 1978.

    Article  PubMed  Google Scholar 

  67. Ritchie KS, Preskorn SH: Mania induced by metoclopramide: Case report. J Clin Psychiatry 45:180–181, 1984.

    PubMed  Google Scholar 

  68. Vlissides DN, Gill D, Castelow MJ: Bromocriptine-induced mania? Br Med J 1:510, 1978.

    Article  PubMed  Google Scholar 

  69. Larson EW, Richelson E: Organic causes of mania. Mayo Clin Proc 63:906–912, 1988.

    Article  PubMed  Google Scholar 

  70. Boston Collaborative Drug Surveillance Program: Acute adverse reactions to prednisone in relation to dosage. Clin Pharmacol 13:694–698, 1972.

    Google Scholar 

  71. Minden SL, Orau J, Schildkraut JJ: Hypomanic reactions to ACTH and prednisone treatment for multiple sclerosis. Neurology 38:1631–1634, 1988.

    Article  PubMed  Google Scholar 

  72. Maxwell S, Scheftner WA, Kessler HA, et al: Manic syndrome associated with zidovudine treatment. JAMA 259:3406, 1989.

    Article  Google Scholar 

  73. Wright JM, Sachdev PS, Perkins RJ, et al: Zidovudine-related mania. Med J Aust 150:339–341, 1989.

    PubMed  Google Scholar 

  74. Waters BGH, Simeon J: Behavioral toxicity to medications in a six year old boy: A genetic marker? J Am Acad Child Psychiatry 22:492–494, 1983.

    Article  PubMed  Google Scholar 

  75. Shader RI: Psychiatric Complications of Medical Drugs. New York: Raven Press, 1972.

    Google Scholar 

  76. Editorial: Br Med J 180:119–120, 1966.

    Google Scholar 

  77. Demuth GW, Ackerman SH: Alpha-methyldopa and depression: A clinical study and a review of the literature. Am J Psychiatry 140:534–538, 1983.

    PubMed  Google Scholar 

  78. Campbell M, Spencer EK: Psychopharmacology in child and adolescent psychiatry: A review of the past five years. J Am Acad Child Adolesc Psychiatry 27:269–279, 1988.

    Article  PubMed  Google Scholar 

  79. Patten SB: Propranolol and depression: Evidence from the antihypertensive trials. Can J Psychiatry 35:257–259, 1990.

    PubMed  Google Scholar 

  80. Brismar K, Hylander B, Eliasson K, et al: Melatonin secretion related to side effects of beta blockers from the central nervous system. Acta Med Scand 223:525–530, 1988.

    Article  PubMed  Google Scholar 

  81. Bright RA, Everitt DE: Beta-blockers and depression: Evidence against an association. JAMA 267:1783–1787, 1992.

    Article  PubMed  Google Scholar 

  82. Hullett FJ, Potkin SG, Levy AB, et al: Depression associated with nifedipine-induced calcium channel blockade. Am J Psychiatry 145:1277–1279, 1988.

    PubMed  Google Scholar 

  83. Caufman M, Kahner K, Paselow ED, et al: Steroid psychoses: Case report and brief overview. J Clin Psychiatry 43:75–76, 1982.

    Google Scholar 

  84. Burke P, Kocoshis SA, Chandra R, et al: Determinants of depression in recent onset paediatric inflammatory bowel disease. J Am Acad Child Adolesc Psychiatry 29:608–610, 1990.

    Article  PubMed  Google Scholar 

  85. Ruthgers AWF, Links TP, LeCoultre R, et al: Behavioral disturbances after effective ACTH treatment of the dancing eye syndrome. Dev Med Child Neurol 30:408, 1988.

    Article  Google Scholar 

  86. Venkatarangam SH, Kutcher SP, Notkin RM: Secondary mania with steroid withdrawal. Can J Psychiatry 33:631–632, 1988.

    PubMed  Google Scholar 

  87. Stiefel FC, Breitbart WS, Holland JC: Corticosteroids in cancer: Neuropsychiatrie complications. Cancer Invest 7:479–491, 1989.

    Article  PubMed  Google Scholar 

  88. Gawkrodger D: Manic depression induced by dapsone in patients with dermatitis herpetiformis. Br Med J 30:860, 1989.

    Article  Google Scholar 

  89. Pope HG Jr, Katz DL: Affective and psychotic symptoms associated with anabolic steroid use. Am J Psychiatry 145:487–490, 1988.

    PubMed  Google Scholar 

  90. Slap GB: Oral contraceptives and depression. Impact, prevalence and cause. J Adolesc Health Care 2:53–64, 1981.

    Article  PubMed  Google Scholar 

  91. Fleming O, Seager CP: Incidence of depressive symptoms in users of the oral contraceptive. Br J Psychiatry 132:431–440, 1978.

    Article  PubMed  Google Scholar 

  92. Glick ID, Bennett SE: Psychiatric complications of progesterone and oral contraceptives. J Clin Psychophar-macol 6:350–367, 1981.

    Article  Google Scholar 

  93. Shear MK: Pathophysiology of panic: A review of pharmacologic provocative tests and naturalistic monitoring data. J Clin Psychiatry 47(suppl):18, 1986.

    PubMed  Google Scholar 

  94. Ministry of Health and Welfare, Tokyo: Angioneurotic oedema induced by enalapril maleate or Captopril. Information on Adverse Reactions to Drugs, No. 84, 1987.

    Google Scholar 

  95. West Midlands Centre for Adverse Drug Reactions Reporting: ACE inhibitors and CNS adverse effects. Newsletter, June 1988.

    Google Scholar 

  96. Burns EM, Arnold LE: Biological aspects of stress: Effects on the developing brain, in: Arnold LE (ed): Childhood Stress. New York: John Wiley & Sons, 173–138, 1990.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ohio State University, Columbus, Ohio, 43210, USA

    L. Eugene Arnold M.Ed., M.D.

  2. Department of Psychiatry, Ohio State University, Columbus, Ohio, 43210, USA

    Igor Janke M.D.

  3. Edgecliff Centre, Edgecliff, New South Wales, 2027, Australia

    Brent Waters M.D., F.R.C.P., F.R.A.N.Z.C.P.

  4. Queenscliff Health Centre, Manly Hospital and Community Health Services, North Manly, New South Wales, 2100, Australia

    Antony Milch M.B.B.S., F.R.A.N.Z.C.P.

Authors
  1. L. Eugene Arnold M.Ed., M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Igor Janke M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Brent Waters M.D., F.R.C.P., F.R.A.N.Z.C.P.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Antony Milch M.B.B.S., F.R.A.N.Z.C.P.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Emeritus Professor of Psychiatry, University of Auckland, Auckland, New Zealand

    John Scott Werry M.D.

  2. Psychology and Psychiatry, The Ohio State University, Columbus, Ohio, USA

    Michael G. Aman Ph.D. (Professor) (Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Science+Business Media New York

About this chapter

Cite this chapter

Arnold, L.E., Janke, I., Waters, B., Milch, A. (1999). Psychoactive Effects of Medical Drugs. In: Werry, J.S., Aman, M.G. (eds) Practitioner’s Guide to Psychoactive Drugs for Children and Adolescents. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0086-9_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-0086-9_13

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-306-45885-9

  • Online ISBN: 978-1-4899-0086-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation